Clinical Research

With increasing requirements from institutional review boards (IRBs) and governmental agencies, partnering with Cambridge Isotope Laboratories, Inc. (CIL) for your next stable isotope cGMP project can help ensure your regulatory compliance. With the world’s largest ¹³C and ¹⁸O isotope-separation plants, CIL is able to provide the raw materials necessary for your project. Your compound of interest most likely already appears on CIL’s extensive list of research compounds – if not, CIL’s team of PhD chemists can determine the best method of synthesis for incorporating ¹³C, ¹⁵N, deuterium, ¹⁷O, and/or ¹⁸O into your compound. CIL has manufactured bulk active pharmaceutical ingredients (APIs) since 1994. It recently added a 15,000-square-foot, state-of-the-art cGMP facility to complement its existing cGMP facilities.